top of page

Topic

Y90 Radioembolization

58 Podcasts • 35 Cases • 4 Courses on BackTable

Hear how experienced physicians approach Y90 Radioembolization on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Radiation Lobectomy Techniques &  Downstaging for HCC
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Vascular & Interventional

Episode # 653  •  09 Jun 2026

Radiation Lobectomy Techniques & Downstaging for HCC

How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases? In this episode of the BackTable 2026 HCC Creator Weekend™, host Dr. Kavi Krishnasamy is joined by interventional radiologists Dr. Beau Toskich and Dr. Chris Malone to explore how downstaging and radiation lobectomy with Y90 are creating new surgical and transplant opportunities for patients with limited future liver remnants. They discuss Y90’s role as a “test of time” for tumor biology, strategies to prevent post-hepatectomy liver failure, and the ongoing challenge of recurrence even after R0 resection in cirrhotic livers.

This podcast is supported by an educational grant from Sirtex and Boston Scientific.

More on Y90 Radioembolization

Loading recent podcasts…

VI

Vascular & IR # 653

Jun 9, 2026

with Dr. Beau Toskich, Dr. Christopher Malone, Dr. Venkatesh Krishnasamy

Radiation Lobectomy Techniques &  Downstaging for HCC

How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases?...

VI

Vascular & IR # 649

May 27, 2026

with Dr. Nima Kokabi, Dr. Riad Salem, Dr. Zach Berman

Y90 Radioembolization Dosimetry: Techniques & Challenges

Can the right dosimetry approach turn palliative Y90 into a curative therapy? In this episode of the BackTable 2026 HCC...

1,100+ listens

Tumor Board

Tumor Board # 59

May 12, 2026

with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart

Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?

With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...

190+ listens

VI

Vascular & IR # 642

May 7, 2026

with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy

Exploring CPN & Radiation Segmentectomy in Liver Cancer

Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...

70+ listens

VI

Vascular & IR # 651

Jun 2, 2026

with Dr. Kirema Garcia-Reyes, Dr. Zach Berman, Dr. Nima Kokabi

Radioembolization Workflow: Insights & Best Practices

What does it really take to run a high-volume Y90 program that is efficient, scalable, and patient-centered? In this...

970+ listens

VI

Vascular & IR # 647

May 21, 2026

with Dr. Juan Gimenez, Dr. Ari Cohen, Dr. Jonathan Mizrahi

Optimizing Liver Cancer Treatment Through Collaboration

In treating hepatocellular carcinoma (HCC), the hardest question often isn’t which treatment to use, it’s who should...

20+ listens

VI

Vascular & IR # 644

May 12, 2026

with Dr. Neil Mehta, Dr. Ari Cohen, Dr. Venkatesh Krishnasamy

Optimizing Liver Transplant Pathways & Decision-Making

A high-functioning HCC tumor board can turn complex transplant decisions into coordinated treatment plans that account...

1,000+ listens

VI

Vascular & IR # 641

May 5, 2026

with Dr. Neil Mehta, Dr. Riad Salem, Dr. Tyler Sandow

Understanding BCLC Updates & Guidelines

With recent updates to the Barcelona Clinic Liver Classification (BCLC), how should multidisciplinary teams adapt their...

1,900+ listens

VI

VI Case

Aug 12, 2025

Y90 Radioembolization: Techniques for Treating Grade 3 Metastatic Neuroendocrine Tumor (NET)

with Dr. Zach Berman and Dr. Christopher Beck

VI

VI Case

Aug 12, 2025

TACE: Treating HCC in Decompensated Liver Cirrhosis (ALBI 3) with Microvascular Optimization

with Dr. Zach Berman and Dr. Christopher Beck

VI

VI Case

Jun 24, 2025

Y90: Treatment Planning for a Small HCC Lesion in a Liver Transplant Candidate

with Dr. Tyler Sandow, Dr. Nima Kokabi and Dr. Venkatesh Krishnasamy

VI

VI Case

Aug 12, 2025

Y90 Radioembolization: HCC with Tumor In Vein

with Dr. Zach Berman and Dr. Christopher Beck

VI

VI Case

Aug 12, 2025

Y90 Radioembolization: Large Cholangiocarcinoma Treatment with Pressure-Enabled Delivery

with Dr. Zach Berman and Dr. Christopher Beck

VI

VI Case

Aug 12, 2025

Y90 Radioembolization: Treating Large Liver Tumors with Segmental Embolization Methods

with Dr. Zach Berman and Dr. Christopher Beck

VI

VI Case

Jul 1, 2025

Y90: Treating a Large Tumor in a Hep B Cirrhosis Patient

with Dr. Nima Kokabi, Dr. Tyler Sandow and Dr. Venkatesh Krishnasamy

Endovascular Management of HCC

VI Course

2 hours, 37 lessons

IR, Surgical & Transplant Collaboration for HCC

Tumor Board Course

2 hours, 22 lessons

Y90 Dosing & Ablation Modalities for HCC

Tumor Board Course

2 hours, 20 lessons

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page